How to buy Bausch Health Companies (BHC) stocks

Bausch Health Companies is a drug manufacturers - specialty & generic business based in Canada. Bausch Health Companies shares (BHC) are listed on the Toronto Stock Exchange (TSX) and all prices are listed in Canadian Dollars.

Its last market close was C$10.71 – a decrease of 3.43% over the previous week. Bausch Health Companies employs 20,270 staff and has a trailing 12-month revenue of around C$9.5 billion.

Our top picks for where to buy Bausch Health Companies stock

Buy Bausch Health Companies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Bausch Health Companies stock price (Toronto Stock Exchange (TSX): BHC)

Use our graph to track the performance of BHC stocks over time.

Bausch Health Companies stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	C$10.71
52-week range	C$5.45 - C$15.43
50-day moving average more info button	C$11.70
200-day moving average more info button	C$10.50
Wall St. target price	C$8.29
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	C$-0.69

Is it a good time to buy Bausch Health Companies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Bausch Health Companies price performance over time

Historical closes compared with the close of C$10.71 from 2024-12-20

1 week (2024-12-13)	-3.43%
1 month (2024-11-22)	-4.12%
3 months (2024-09-20)	-1.65%
6 months (2024-06-21)	15.29%

1 year (2023-12-21)	7.96%
2 years (2022-12-21)	13.82%
3 years (2021-12-21)	34.66
5 years (2019-12-20)	39.44

Is Bausch Health Companies stock undervalued or overvalued?

Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bausch Health Companies's PEG ratio

Bausch Health Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.0175. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bausch Health Companies's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Bausch Health Companies's EBITDA

Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is C$3.1 billion.

The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.

Bausch Health Companies financials

Revenue TTM	C$9.5 billion
Operating margin TTM	21.67%
Gross profit TTM	C$5.8 billion
Return on assets TTM	4.15%
Return on equity TTM	-2304.54%
Profit margin	-1.88%
Book value	C$-3.19
Market Capitalization more info button	C$3.9 billion
EBITDA more info button	C$3.1 billion

TTM: trailing 12 months

Bausch Health Companies stock dividends

We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.

Have Bausch Health Companies's stocks ever split?

Bausch Health Companies's stocks were split on a 2:1 basis on 4 October 2000 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Bausch Health Companies stocks, which in turn could have impacted Bausch Health Companies's stock price.

Bausch Health Companies stock price volatility

Over the last 12 months, Bausch Health Companies's stocks have ranged in value from as little as C$5.45 up to C$15.43. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while Bausch Health Companies's is 0.745. This would suggest that Bausch Health Companies's stocks are less volatile than average (for this exchange).

Bausch Health Companies overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Bausch Health Companies is owned by insiders or institutions?
Currently 11.066% of Bausch Health Companies stocks are held by insiders and 72.022% by institutions. How many people work for Bausch Health Companies?
Latest data suggests 20,270 work at Bausch Health Companies. When does the fiscal year end for Bausch Health Companies?
Bausch Health Companies's fiscal year ends in December. Where is Bausch Health Companies based?
Bausch Health Companies's address is: 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 What is Bausch Health Companies's ISIN number?
Bausch Health Companies's international securities identification number is: CA0717341071

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.